Case News
Aug 16

More Drug Makers Tagged as Valsartan Recall Grows

by Madelyn Dunlap

Originally posted on WebMD by Patrice Wendling on August 13, 2018. European and U.S. health officials are expanding their recall of valsartan after the potentially cancer-causing substance N-nitrosodimethylamine (NDMA) was found in some medications made by a second Chinese drugmaker and by a drugmaker in India. More than 20 European countries, Canada, and the… read more

Case News
Aug 13

Probiotic use is a link between brain fogginess, severe bloating

by Madelyn Dunlap

Originally posted on EurekAlert! on August 6, 2018. AUGUSTA, Ga. (Aug. 6, 2018) – Probiotic use can result in a significant accumulation of bacteria in the small intestine that can result in disorienting brain fogginess as well as rapid, significant belly bloating, investigators report. In a published study of 38… read more

Case News
Jul 26

Bipartisan group wants ‘immediate’ PFAS safety levels update

by Madelyn Dunlap

Originally posted on MLive by Garret Ellison on July 17, 2018. A bipartisan group of Congressional delegates from Michigan and Pennsylvania want the Environmental Protection Agency to “immediately” revise and broaden its health guidance for PFAS chemicals and incorporate new a toxicological study that significantly lowers levels at which exposure… read more

Case News
Jul 18

Blood Pressure Medicine Is Recalled

by Madelyn Dunlap

Originally posted by NY Times by Sheila Kaplan on July 16, 2017. The Food and Drug Administration has announced a voluntary recall of a widely prescribed blood pressure medication made in China, reviving fears about the safety of imported drugs. Three companies that sell the generic drug, valsartan, in the United States… read more